search
Company Information
USD
67.39
- (1.3%)
NASDAQ:LNTH, LANTHEUS HOLDINGS, INC.
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 1 May 2024 GMT-4
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products.  Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Address

201 Burlington Road
South Building

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - Specialty & Generic

Key Executives

Mr. Brian A. Markison
CEO
Ms. Mary Anne Heino
Chairman of the Board/Director
Ms. Julie H. McHugh
Director
Dr. James H. Thrall
Director
Mr. Samuel R. Leno
Director
Mr. Gary John Pruden
Director
Ms. Minnie V. Baylor-Henry
Director
Mr. Robert J. Marshall, Jr
CFO/Treasurer
Dr. Gerard Ber, PhD
Director
Mr. Paul M. Blanchfield
President/President, Subsidiary
Mr. Heinz Mausli
Director
Mr. Daniel M. Niedzwiecki
Chief Administrative Officer/General Counsel/Secretary
Ms. Andrea Sabens
Chief Accounting Officer
Mr. Etienne Montagut
Other Executive Officer
Dr. Jean-Claude Provost
Chief Medical Officer

Ownership

Institution Holdings

BlackRock Inc
8,466,740 (12.356%)
Vanguard Group Inc
6,973,141 (10.176%)
BlackRock Fund Advisors
5,023,621 (7.331%)
HHG PLC
3,947,571 (5.761%)
Fidelity Management & Research Company LLC
2,927,005 (4.271%)
Janus Capital Management LLC
2,610,767 (3.810%)
State Street Corporation
2,398,859 (3.501%)
FMR Inc
2,331,134 (3.402%)
Vanguard Investments Australia Ltd
2,169,882 (3.167%)
AllianceBernstein L.P.
1,969,972 (2.875%)

Individual Holdings

Mr. John W. Crowley
161,825 (0.426%)
Ms. Mary Anne Heino
251,643 (0.367%)
Mr. Robert J. Marshall, Jr
169,479 (0.247%)
Mr. Brian A. Markison
152,826 (0.223%)
Mr. Paul M. Blanchfield
142,108 (0.207%)
Mr. Etienne Montagut
120,225 (0.175%)
Mr. Daniel M. Niedzwiecki
103,217 (0.151%)
Ms. Andrea Sabens
69,905 (0.102%)
Mr. Samuel R. Leno
57,937 (0.085%)
Mr. Gary John Pruden
32,957 (0.048%)

Funds Holdings

Vanguard Total Stock Market Index Fund
2,155,428 (3.145%)
Vanguard US Total Market Shares ETF
2,155,428 (3.145%)
iShares Core S&P Mid-Cap ETF
2,084,953 (3.043%)
Vanguard Small Cap Index
1,749,012 (2.552%)
iShares Russell 2000 ETF
1,660,971 (2.424%)
Vanguard Institutional Extnd Mkt Idx Tr
1,013,957 (1.480%)
Vanguard Small Cap Growth Index Fund
975,586 (1.424%)
Macquarie US Small Cap Core Equity
962,944 (1.405%)
Delaware Small Cap Core Fund
951,537 (1.389%)
Janus Henderson Triton Fund
862,149 (1.258%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices